Target intelligence / Profile preview

Tight junction and adhesion proteins

Molecular classification
Cell adhesion molecule, Membrane protein, Structural protein, Receptor
01

Overview

Tight junction and adhesion proteins are a diverse group of transmembrane and cytoplasmic proteins that mediate cell-cell contact and maintain the structural integrity of epithelial and endothelial barriers (Source: StatPearls, NBK541079). Tight junctions, composed of proteins like claudins, occludins, and zonula occludens, regulate the paracellular pathway, controlling the flow of ions and solutes while preventing the entry of pathogens (Source: PMID: 28215312). Adhesion proteins, such as cadherins and integrins, provide mechanical strength and facilitate intracellular signaling pathways that govern cell growth, differentiation, and migration (Source: UniProt). In many diseases, particularly cancer and inflammatory conditions, these proteins are dysregulated, leading to leaky barriers or facilitating the epithelial-mesenchymal transition (EMT) and subsequent metastasis (Source: PMID: 33431110). Therapeutic strategies targeting these proteins include monoclonal antibodies that induce cell death in claudin-expressing tumors or small molecules that modulate barrier permeability for enhanced drug delivery (Source: DrugBank). However, because these proteins are widely expressed in healthy tissues, therapeutic targeting requires high specificity to avoid systemic barrier disruption and associated toxicities (Source: PMID: 30635924).

Other names
Cell-cell junction proteinsIntercellular adhesion moleculesJunctional complex proteinsBarrier proteins
02

Mechanism of action

Antibody-dependent cellular cytotoxicity (ADCC), inhibition of leukocyte trafficking, modulation of paracellular permeability, and competitive antagonism of cell-surface adhesion receptors.

03

Biological functions

Cell-cell adhesionBarrier functionParacellular transportCell polaritySignal transduction
04

Disease associations

CancerInflammationInfectionAutoimmune diseaseGastrointestinal disease
05

Safety considerations

Gastrointestinal distressIncreased risk of opportunistic infectionsPotential for systemic vascular or epithelial leakageInfusion-related reactions
06

Interacting drugs

Zolbetuximab

5 more in the full profile.

07

Biomarkers

CLDN18.2 expressionE-cadherin downregulationZonulin concentrationSoluble ICAM-1

Beyond the preview

Go deeper on Tight junction and adhesion proteins.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tight junction and adhesion proteins.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call